⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1394157 | 0.98 | — | — | |
| SCHEMBL2214349 | 0.87 | — | — | |
| SCHEMBL8056747 | 0.86 | — | — | |
| SCHEMBL8056765 | 0.86 | — | — | |
| SCHEMBL8056098 | 0.86 | — | — | |
| SCHEMBL8062660 | 0.86 | — | — | |
| SCHEMBL769659 | 0.84 | — | — | |
| SCHEMBL8056819 | 0.84 | — | — | |
| SCHEMBL8060465 | 0.83 | — | — | |
| SCHEMBL769667 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080261973-A1 | Sulphonamidoaniline Derivatives Being Janus Kinase Inhibitors | NOVARTIS AG (CH) | 2008-10-23 | — | — | US | claimed |
| US-20080261973-A1 | Sulphonamidoaniline Derivatives Being Janus Kinase Inhibitors | NOVARTIS AG (CH) | 2008-10-23 | — | — | US | disclosed |